Education
About Us
Working with TipRanks
Follow Us
Auna S.A. Class A (AUNA)
NYSE:AUNA
Top Page
Auna S.A. Class A
(NYSE:AUNA)
59Neutral
Auna S.A. Class A (AUNA) vs. S&P 500 (SPY)
Market Cap
$213.30M
Dividend YieldN/A
Average Volume (3M)31.51K
Price to Earnings (P/E)―
Beta (1Y)1.58
Revenue Growth18.77%
EPS Growth-39.97%
CountryUS
Employees14,734
SectorGeneral
Sector StrengthN/A
IndustryMedical - Care Facilities
Share Statistics
EPS (TTM)-0.98
Shares Outstanding30,000,000
10 Day Avg. Volume28,946
30 Day Avg. Volume31,513
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)0.50
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
$13.50Price Target Upside89.87% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
Auna S.A. Class A Business Overview & Revenue Model
Company DescriptionAuna S.A. Class A (AUNA) is a leading healthcare services provider in Latin America, primarily operating in Peru and Colombia. The company offers a comprehensive range of healthcare services through its network of hospitals, clinics, and outpatient facilities. Auna S.A. is dedicated to delivering high-quality medical care and innovative health solutions to improve patient outcomes and enhance the overall healthcare experience in the regions it serves.
How the Company Makes MoneyAuna S.A. generates revenue primarily through the provision of medical services across its extensive network of healthcare facilities. The company earns income from a mix of direct payments from patients and reimbursements from insurance providers. Key revenue streams include hospital admissions, outpatient services, diagnostic services, and specialty care. Additionally, Auna S.A. benefits from strategic partnerships with insurance companies and government healthcare programs, which help ensure a steady flow of patients and financial stability. The company's focus on expanding its facility network and enhancing service offerings also plays a crucial role in driving revenue growth.
Auna S.A. Class A Financial Statement Overview
Summary
Auna S.A. demonstrates solid financial health with strong revenue growth and improved profitability margins, reflecting effective cost management and operational efficiencies. While leverage remains a concern, the company's ability to generate cash flow and manage debt levels has improved.Income Statement
Auna S.A. demonstrated a strong revenue growth of 13.17% from 2023 to 2024, continuing a positive trend with a significant leap from 2022. The gross profit margin improved to 39.32%, while the net income turned positive after two consecutive years of losses, resulting in a net profit margin of 2.51%. EBIT and EBITDA margins also showed healthy improvements, indicating enhanced operational efficiency.78
Positive
Balance Sheet
The company maintains a relatively high debt-to-equity ratio of 2.6, indicating significant leverage but a reduction from prior years. The equity ratio improved to 20.86%, reflecting better capital structure management. However, the return on equity remains modest at 7.47%, suggesting room for improvement in generating returns for shareholders.62
Positive
Cash Flow
Auna S.A. experienced a robust 38.36% growth in free cash flow in 2024, supported by strong operating cash flow. The operating cash flow to net income ratio is a healthy 6.06, showcasing efficient cash conversion. The free cash flow to net income ratio of 5.24 highlights the company's ability to generate cash relative to its net profit.75
Positive
| Breakdown | ||||
| Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|
| Income Statement | Total Revenue | |||
| 4.39B | 3.88B | 2.45B | 1.92B | 1.44B | Gross Profit |
| 1.73B | 1.44B | 879.70M | 686.93M | 529.43M | EBIT |
| 783.76M | 560.34M | 254.59M | 108.14M | 118.42M | EBITDA |
| 975.27M | 647.30M | 299.14M | 170.15M | 108.36M | Net Income Common Stockholders |
| 110.27M | -253.92M | -85.61M | -26.47M | -7.10M |
| Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | |||
| 335.97M | 334.26M | 208.69M | 138.77M | 343.45M | Total Assets |
| 7.08B | 7.69B | 6.59B | 2.82B | 2.65B | Total Debt |
| 3.84B | 3.92B | 3.51B | 1.49B | 1.35B | Net Debt |
| 3.61B | 3.68B | 3.30B | 1.35B | 1.01B | Total Liabilities |
| 5.46B | 5.91B | 5.04B | 2.28B | 2.00B | Stockholders Equity |
| 1.48B | 1.47B | 1.06B | 495.82M | 600.93M |
| Cash Flow | Free Cash Flow | |||
| 577.64M | 417.25M | 10.67M | -106.03M | 27.38M | Operating Cash Flow |
| 668.50M | 582.41M | 162.64M | 183.34M | 156.30M | Investing Cash Flow |
| -236.82M | -173.15M | -3.21B | -291.99M | -125.93M | Financing Cash Flow |
| -418.12M | -370.00M | 3.13B | -102.13M | 272.70M |
Auna S.A. Class A Technical Analysis
Negative
7.11
Price Trends
7.92
Negative
7.44
Negative
7.51
Negative
Market Momentum
-0.20
Negative
41.64
Neutral
62.99
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For AUNA, the sentiment is Negative. The current price of 7.11 is below the 20-day moving average (MA) of 7.34, below the 50-day MA of 7.92, and below the 200-day MA of 7.51, indicating a bearish trend. The MACD of -0.20 indicates Negative momentum. The RSI at 41.64 is Neutral, neither overbought nor oversold. The STOCH value of 62.99 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for AUNA.
Auna S.A. Class A Peers Comparison
Overall Rating
UnderperformOutperform
Sector (54)
Financial Indicators
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
79 Outperform | $17.66B | 16.13 | 27.07% | ― | 19.24% | 8.57% | |
75 Outperform | $30.12B | 9.72 | 12.65% | ― | 5.89% | 27.09% | |
73 Outperform | $89.19B | 27.13 | 7.87% | 1.72% | 25.21% | -29.37% | |
67 Neutral | $31.94B | 26.50 | 7.40% | 1.34% | 10.70% | -49.85% | |
65 Neutral | $472.03B | 33.28 | 15.88% | 1.58% | 8.35% | -35.14% | |
59 Neutral | $213.30M | ― | -7.76% | ― | 18.77% | -39.97% | |
54 Neutral | $4.11B | -18.71 | -17.06% | 5.82% | 26.02% | -79.79% |
* General Sector Average
Performance Comparison
AUNA
Auna S.A. Class A
7.17
-2.71
-27.43%
CNC
Centene
60.45
-12.00
-16.56%
CI
Cigna
331.00
-25.96
-7.27%
HUM
Humana
264.74
-35.97
-11.96%
MOH
Molina Healthcare
327.71
-53.21
-13.97%
UNH
UnitedHealth
523.12
72.19
16.01%
Auna S.A. Class A Earnings Call Summary
Earnings Call Date: Mar 10, 2025 | % Change Since: -11.12% | Next Earnings Date: May 21, 2025
Earnings Call Sentiment Positive
The earnings call highlighted significant growth in adjusted EBITDA, revenue growth in key markets like Mexico and Peru, and improvement in debt leverage. However, challenges in Colombia, specifically related to provisions for impairment losses, pose a concern. Overall, the positive developments in various regions and financial metrics outweigh the challenges faced in Colombia.Highlights
Record Adjusted EBITDA Growth
Adjusted EBITDA increased by 23% on an FX-neutral basis with a margin expansion of 1.4 percentage points. Mexico and Peru reached record highs with Mexico's adjusted EBITDA increasing by 34%.
Revenue Growth in Key Markets
Regional platform revenues increased by 13% year-over-year to PEN 1.1 billion, led by Mexico and Peru, which grew 16% and 13%, respectively.
Debt Leverage Improvement
Net debt to adjusted EBITDA ratio fell below 4x to 3.7x, marking the eighth consecutive quarter of improving leverage since the acquisition in 2022.
Positive Performance in Peru
Revenue grew 13% with adjusted EBITDA increasing nearly 50%, and margin expanded by 5.3 percentage points to 21.6%.
Lowlights
Challenges in Colombia
Adjusted EBITDA decreased by 18% due to increased provisions for impairment losses, impacting the margin which decreased by 4.5 percentage points to 12.4%.
Provision for Impairment Losses
Increased provision for impairment losses in Colombia by PEN 16 million due to less predictable payments from payers.
Company Guidance
During the third quarter 2024 earnings call for Auna, the company provided guidance that highlighted significant financial metrics and strategic outlooks. Adjusted EBITDA increased by 23% year-over-year on an FX-neutral basis, with margins expanding by 1.4 percentage points. In terms of regional performance, Mexico and Peru saw record highs in adjusted EBITDA, with Mexico's adjusted EBITDA increasing by 34% and its margin growing by 4.7 percentage points to nearly 36%. Auna's overall regional platform revenues grew by 13% to PEN 1.1 billion, driven by 16% growth in Mexico and 13% in Peru. The company's debt leverage improved, with the net debt to adjusted EBITDA ratio falling below 4x for the first time since the acquisition in Mexico, marking the eighth consecutive quarter of leverage reduction. Additionally, consolidated revenue grew 13% and adjusted EBITDA increased 23% on an FX-neutral basis, while the margin improved by 1.4 percentage points to over 22%. The company remains optimistic about its long-term growth strategies in Mexico and Colombia, with a focus on implementing the AunaWay and expanding its oncological services.Glossary
OutperformA stock rated as "Outperform" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests that the stock is likely to deliver higher returns compared to the average returns of other stocks in the same sector or market index. Investors might consider this stock a good buying opportunity.
NeutralA stock rated as "Neutral" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly attractive nor unattractive for investment. Investors may consider holding onto the stock, as it is not expected to either significantly outperform or underperform the market.
UnderperformA stock rated as "Underperform" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests that the stock may deliver lower returns compared to the average returns of other stocks in the same sector or market index. Investors might consider selling the stock or avoiding it as an investment.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.